Spatacsin regulates directionality of lysosome trafficking by promoting the degradation of its partner AP5Z1

PLoS Biol. 2023 Oct 23;21(10):e3002337. doi: 10.1371/journal.pbio.3002337. eCollection 2023 Oct.

Abstract

The endoplasmic reticulum (ER) forms contacts with the lysosomal compartment, regulating lysosome positioning and motility. The movements of lysosomes are controlled by the attachment of molecular motors to their surface. However, the molecular mechanisms by which ER controls lysosome dynamics are still elusive. Here, using mouse brain extracts and mouse embryonic fibroblasts, we demonstrate that spatacsin is an ER-resident protein regulating the formation of tubular lysosomes, which are highly dynamic. Screening for spatacsin partners required for tubular lysosome formation showed spatacsin to act by regulating protein degradation. We demonstrate that spatacsin promotes the degradation of its partner AP5Z1, which regulates the relative amount of spastizin and AP5Z1 at lysosomes. Spastizin and AP5Z1 contribute to regulate tubular lysosome formation, as well as their trafficking by interacting with anterograde and retrograde motor proteins, kinesin KIF13A and dynein/dynactin subunit p150Glued, respectively. Ultimately, investigations in polarized mouse cortical neurons in culture demonstrated that spatacsin-regulated degradation of AP5Z1 controls the directionality of lysosomes trafficking. Collectively, our results identify spatacsin as a protein regulating the directionality of lysosome trafficking.

MeSH terms

  • Adaptor Proteins, Vesicular Transport* / metabolism
  • Animals
  • Dyneins / metabolism
  • Fibroblasts* / metabolism
  • Lysosomes / metabolism
  • Mice
  • Neurons / metabolism
  • Proteins* / metabolism

Substances

  • Dyneins
  • Proteins
  • SPG11 protein, mouse
  • Adaptor Proteins, Vesicular Transport

Grants and funding

This work was supported by “Investissements d’Avenir” program [ANR-10-IAIHU-06] and [ANR-11-INBS-0011] grants. The NeurImag Imaging Facility team is member of the national infrastructure France-BioImaging supported by the French National Research Agency (ANR-10-INBS-04). The work was supported by funding from the European Research Council (European Research Council Starting [grant No 311149] to F.D.). M.B. received a fellowship from the French Ministry of Research (doctoral school ED3C). A.P. received an ARDOC fellowship from the Région Ile de France (grant 17012953; doctoral school ED3C) and a fellowship from the Fondation pour la Recherche Médicale (grant FDT202001010829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.